Two adolescent patients with coexistent Graves' disease and Moyamoya disease in Korea

Chong Kun Cheon1, Su Yung Kim1, Jae-Ho Yoo2

  • 1Department of Pediatrics, Pusan National University School of Medicine, Yangsan, Korea.

Insights

Moyamoya disease, a rare cerebrovascular condition, was diagnosed in two adolescent girls with Graves

Area of Science:

  • Neurology and Endocrinology
  • Cerebrovascular Diseases
  • Autoimmune Disorders

Background:

  • Moyamoya disease involves progressive narrowing of cerebral arteries at the base of the brain.
  • Graves' disease is an autoimmune disorder affecting the thyroid gland.
  • The co-occurrence of Moyamoya disease and Graves' disease, particularly in adolescents, is rare and poorly understood.

Purpose of the Study:

  • To report two adolescent cases of Moyamoya disease associated with Graves' disease.
  • To investigate the potential link between these two conditions in a euthyroid state.
  • To highlight the importance of recognizing this association for timely diagnosis and treatment.

Main Methods:

  • Case study of two adolescent patients presenting with hemiparesis and syncope.
  • Diagnostic evaluation included thyroid function tests and neuroimaging (MRA, cerebral angiography).
  • Treatment involved cranial revascularization surgery (encephalo-duroarterio-synangiosis).

Main Results:

  • Both patients were diagnosed with Moyamoya disease and Graves' disease, presenting as euthyroid with elevated TSH receptor antibodies.
  • Cranial revascularization surgery led to successful resolution of neurological symptoms.
  • Patients experienced positive outcomes with no further neurological complications at follow-up.

Conclusions:

  • This report details the first known cases in South Korea of adolescent Moyamoya disease associated with Graves' disease in a euthyroid state.
  • The findings suggest a possible, though obscure, relationship between Moyamoya disease and Graves' disease that warrants further investigation.
  • Early surgical intervention for Moyamoya disease can lead to favorable neurological outcomes.

Related Concept Videos

Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
15
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
17
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
25
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
21
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
25
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
18